T-CELL RECEPTOR AND IMMUNOGLOBULIN GENE REARRANGEMENTS IN CUTANEOUS T-CELL-RICH PSEUDOLYMPHOMAS

被引:29
作者
GRIESSER, H
FELLER, AC
STERRY, W
机构
[1] UNIV KIEL,DEPT DERMATOL,W-2300 KIEL 1,GERMANY
[2] UNIV WURZBURG,DEPT PATHOL,W-8700 WURZBURG,GERMANY
关键词
D O I
10.1111/1523-1747.ep12484964
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
T-cell rich, small lymphoid infiltrates of the skin may cause considerable problems in the differential diagnosis of reactive versus neoplastic lymphoproliferations, particularly when they lack the morphologic and immunophenotypical criteria for a malignant lymphoma. We did histologic, immunohistologic, and gene rearrangement studies on 10 biopsies from patients with persistent nodular T-cell-rich skin lesions refractory to topical therapy. Based on clinical and immunohistochemical findings, no discrimination was possible between reactive lesions and malignant lymphoproliferations. Histologically, most of the cases contained T-lymphocytic infiltrations that were assumed to be reactive; however, in four biopsies a neoplastic infiltration could not be excluded. Although the T-cell receptor (TCR) β chain and the immunoglobulin heavy chain (IgH) genes were in germ-line configuration in nine of 10 cases, indicating a predominantly polyclonal lymphocellular infiltrate, in one patient without clinical evidence of malignant lymphoma at presentation a clonally rearranged TCR β chain gene with the IgH gene in germ-line configuration was detected. One year later, the patient developed a cutaneous pleomorphic T-cell lymphoma and subsequently a large cell anaplastic (CD30+) T-cell lymphoma in an inguinal lymph node. We conclude that clonal T-cell proliferations can be detected by molecular genetic analysis of T-cell-rich, small lymphoid infiltrates of the skin. This finding may precede development of an overt malignant T-cell lymphoma. © 1990.
引用
收藏
页码:292 / 295
页数:4
相关论文
共 27 条
[1]  
ALLDAY MJ, 1988, LANCET, V1, P855
[2]   T-CELL RECEPTOR GENE REARRANGEMENTS [J].
BLEICHER, PA ;
BALK, SP .
ARCHIVES OF DERMATOLOGY, 1988, 124 (03) :359-363
[3]  
BURG G, 1981, HAUTARZT S, V32, P210
[4]  
ECKERT F, 1988, ZBL HAUT GSHLKR, V154, P614
[5]  
EVANS HL, 1979, CANCER, V44, P699, DOI 10.1002/1097-0142(197908)44:2<699::AID-CNCR2820440243>3.0.CO
[6]  
2-J
[7]  
GARTMANNH, 1980, Z HAUTKRANKHEITEN, V55, P166
[8]   REARRANGEMENT OF THE BETA-CHAIN OF THE T-CELL ANTIGEN RECEPTOR AND IMMUNOGLOBULIN GENES IN LYMPHOPROLIFERATIVE DISORDERS [J].
GRIESSER, H ;
FELLER, A ;
LENNERT, K ;
MINDEN, M ;
MAK, TW .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1179-1184
[9]  
GRIESSER H, 1989, BLOOD, V73, P1402
[10]  
HANTO DW, 1981, SURGERY, V90, P204